Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation

Bone Marrow Transplantation

Volumn 38, Issue 9, 2006, Pages 609-614

  Parkins, M D ^a   Bahlis, N ^a,b   Brown, C ^a,b   Savoie, L ^a,b   Chaudhry, A ^b   Russell, J A ^a,b   Stewart, D A ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADULT; AGED; APHERESIS; AUTOGRAFT; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BLOOD STORAGE; CANADA; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CD34 SELECTION; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; DISEASE FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; BLOOD COMPONENT REMOVAL; CRYOPRESERVATION; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33750182693     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705501     Document Type: Review

References (20)

1. Stewart DA, Guo D, Luider J, Auer 1, Klassen J, Ching E et al. Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose. Bone Marrow Transplant 1999; 23: 1237-1243.
2. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360-1377.
3. Jestice HK, Scott MA, Ager S, Tolliday BH, Marcus RE. Liquid storage of peripheral blood progenitor cells for transplantation. Bone Marrow Transplant 1994; 14: 991-994.
4. Hechler G, Weide R, Heymanns J, Koppler H, Havemann K. Storage of noncryopreserved periphered blood stem cells for transplantation. Ann Hematol 1996; 72: 303-306.
5. Pettengell R, Woll PJ, O'Connor DA, Dexter TM, Testa NG. Viability of haernopoietic progenitors from whole blood, bone marrow and leukapheresis product: Effects of storage media, temperature and time. Bone Marrow Transplant 1994; 14: 703-706.
6. Beaujean F, Pico J, Norol F, Divine M, Le Forestier C, Duedari N. Characteristics of peripheral blood progenitor cells frozen after 24h of liquid storage. J Hematother 1996; 5: 681-686.
7. de Kreuk AM, Jonkhoff AR, Zevenbergen A, Hendriks EC, Schuurhuis GJ, Ossenkoppele GJ et al. Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days. Bone Marrow Transplant 2001; 28: 145-155.
8. Sugrue MW, Hutcheson CE, Fisk DD, Roberts CG, Mageed A, Wingard JR et al. The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost. J Hematother 1998; 7: 431-436.
9. Lazarus HM, Pecora AL, Shea TC, Koc ON, White JM, Gabriel DA et al. CD34+ selection of hernatopoictic blood cell collections and autotransplantation in lymphoma: Overnight storage of cells at 4 degrees C does not affect outcome. Bone Marrow Transplant 2000; 25: 559-566.
10. Meehan KR, Areman EM, Ericson SG, Matias C, Seifeldin R, Schulman K. Mobilization, collection, and processing of autologous peripheral blood stem cells: Development of a clinical process with associated costs. J Hematother Stem Cell Res 2000; 9: 767-771.
11. Magrin S, Gentile S, Santoro A, Indovina A, Scime R, Hauser D et al. Collection, processing and storage of peripheral blood stem cells (PBSC). Haematologica 1991; 76 (Suppl 1): 55-57.
12. Reiffers J, Cailliot C, Dazey B, Attal M, Caraux J, Boiron JM. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34-positive cells. Lancet 1999; 354: 1092-1093.
13. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W et al. Ex vivo expanded peripheral blood progenitor cellsprovide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001-3007.
14. Stewart DA, Guo D, Luider J, Auer I, Klassen J, Morris D et al. A low CD34 + cell dose predicts relapse and death early following autologous blood stem cell transplantation. Hematol 2001; 6: 19-27.
15. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
16. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favourable variables for rapid engraftment in 225 patients. Blood 1995; 85: 598-596.
17. Gandhi MK, Jestice K, Scott MA, Bloxham D, Bass G, Marcus RE. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplant 1999; 23: 9-13.
18. Koc ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G et al. Autologous CD34 + cell transplantation for patients with advanced lymphoma: Effects of overmight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant 1999; 21: 337-343.
19. Friedman J, Lazarus HM, Koc ON. Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplant 2000; 26: 831-836.
20. Widmer L, Pichert G, Jost LM, Stahel RA. Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hernatopoietic progenitor cells. Blood 1996; 88: 3166-3175.